Printer Friendly
The Free Library
4,547,008 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Zacks Analyst Blog Highlights: ConocoPhillips, EnCana and Esterline Corporation.


CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: ConocoPhillips (NYSE: COP), EnCana (NYSE: ECA) and Esterline Corporation (NYSE: ESL).

See the latest posts to the Analyst Blog by visiting: http://at.zacks.com/?id=2673

Here are highlights from Wednesday's Analyst Blog:

COP's Strong Position Continues

Our continued positive view of ConocoPhillips (NYSE: COP) shares reflects the company's strong position in the politically stable OECD [Organization for Economic Cooperation and Development] markets and attractive valuation. The company has significantly strengthened its upstream portfolio through its Burlington and LUKOIL transactions, and remains a premier domestic refining player.

Recent alliance with EnCana (NYSE: ECA) further cements its upstream and downstream prospects. With balance sheet leverage almost within management's target range and capital expenditures expected to remain around current levels over the next few years, the company is expected to deploy the bulk of its excess cash flows towards shareholder returns. Buybacks are expected to be around $4 billion this year.

Our unchanged target price of $80 results from applying 2007 P/E [price-to-earnings] and P/CF [price-to cash-flow] multiples of 8.6x and 5.4x, respectively - still at discounts to the super majors. Despite these positive attributes, the stock is the cheapest in the group, based on all conventional valuation metrics. We believe that greater appreciation of the company's repositioned upstream asset portfolio following the Burlington and Lukoil deals and its strong U.S. refining footprint will help it narrow its valuation discount.

Bullish on Esterline Corp.

Esterline Corporation (NYSE: ESL) is still in a splendid position to take advantage of the upcoming surge in deliveries of commercial aircraft as well as whatever level of spending is approved by federal bureaucracies, both domestically and abroad. Through a number of acquisitions (the latest being CMC on March 14, 2007), it has expanded its capabilities to the point that it has now entered the arena of systems integrators.

It does not appear to this writer that the market has yet fully appreciated ESL's earning possibilities, as the company transitions from a period of higher spending on research, development, test and evaluation [R, D, T&E] for new aircraft to the actual production of a variety of models. Increased levels of income are indeed foreseeable over the next decade.

See the latest posts to the Analyst Blog by visiting http://at.zacks.com/?id=2645

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2674.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 22, 2007
Words:646
Previous Article:China Premium Lifestyle Signs Agreement with Falber Confezioni for Exclusive Distribution of Designer John Richmond Apparel in Asia.
Next Article:EPIX Pharmaceuticals to Present at the BioCentury Investment Conference: Future Leaders in the Biotech Industry.
Topics:



Related Articles
Zacks Analyst Blog Highlights: AtheroGenics, AstraZeneca, Campbell Soup and SAP.
Zacks Analyst Blog Highlights: Palm, Inc., Research in Motion, Motorola and Morgan Stanley.
Zacks Analyst Blog Highlights: 3Com Corporation and W.R. Berkley.
Zacks Analyst Blog Highlights: Schering-Plough, Merck, CNOOC and Sinopec.
Zacks Analyst Blog Highlights: Logitech, Microsoft and Pool Corporation.
Zacks Analyst Blog Highlights: LabCorp, United Healthcare, Aetna and Quest Diagnostics.
Zacks Analyst Blog Highlights: FactSet, ConocoPhillips, EnCana and Jones Lang LaSalle.
Zacks Analyst Blog Highlights: Bayer A.G. and Jones Soda.
Zacks Analyst Blog Highlights: EnCana, ConocoPhillips, Ultra Clean and H&R Block.
Zacks Analyst Blog Highlights: Thomson Corporation, Reuters and International Rectifier.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles